- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 27, 2026 | 268.19M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 271M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 276M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $836M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $241M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $270M |
| Dividends Paid | Q1 2026 · Mar 31, 2025 | $148M |
| Capex | Q1 2026 · Mar 31, 2026 | $500M |
| Capex | Q1 2026 · Mar 31, 2025 | $428M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $1.83B |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $1.63B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $1.45B |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $3.18B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $512M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $825M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $9.81B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $10.04B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $11.07B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $12.06B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $31.96B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $31.37B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.2B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.21B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $41.99B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $41.62B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $3.48 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $2.70 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $3.49 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $2.71 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $582M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $562M |
| Net Income | Q1 2026 · Mar 31, 2026 | $941M |
| Net Income | Q1 2026 · Mar 31, 2025 | $730M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $1.16B |
| Operating Income | Q1 2026 · Mar 31, 2025 | $945M |
| Revenue | Q1 2026 · Mar 31, 2026 | $4.45B |
| Revenue | Q1 2026 · Mar 31, 2025 | $4B |